Dr. Reddy’s Laboratories informs about press release

20 Jan 2023 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe’.

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1221.90 -18.10 (-1.46%)
28-Jan-2026 14:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1606.30
Dr. Reddys Lab 1221.90
Cipla 1320.00
Zydus Lifesciences 891.65
Lupin 2125.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×